As targets of CCBs, genetically predicted levels of CACNA1C (OR=4.64, 95% CI: 1.13-19.0, p=0.033) and CALM1 (OR=1.37, 95% CI: 1.01-1.85, p=0.045) might increase the risk of kidney cancer. Here, CACNA1C is linked to kidney cancer.